Molecular genetic background of an autosomal dominant hypercholesterolemia in the Czech Republic
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
28379029
DOI
10.33549/physiolres.933587
PII: 933587
Knihovny.cz E-zdroje
- MeSH
- apolipoprotein B-100 genetika MeSH
- genetická variace genetika MeSH
- genetické pozadí * MeSH
- hyperlipoproteinemie typ II krev epidemiologie genetika MeSH
- LDL-cholesterol krev genetika MeSH
- LDL-receptory genetika MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Názvy látek
- APOB protein, human MeSH Prohlížeč
- apolipoprotein B-100 MeSH
- LDL-cholesterol MeSH
- LDL-receptory MeSH
- LDLR protein, human MeSH Prohlížeč
Autosomal dominant hypercholesterolemia (ADH), more known as familial hypercholesterolemia (FH), is a lipid metabolism disorder characterized by an elevation in low-density lipoprotein cholesterol (LDL-C) and increased risk for cardiovascular disease. In this study, we assessed a spectrum of mutations causing ADH in 3914 unrelated Czech patients with clinical diagnosis of hypercholesterolemia. Samples have been collected within the framework of the MedPed project running in the Czech Republic since 1998. So far we have found 432 patients (11.0 %) with the APOB gene mutation p.(Arg3527Gln) and 864 patients (22.1 %) with the LDLR gene mutation. In 864 probands carrying the LDLR gene mutation, 182 unique allelic variants were detected. We have identified 14 patients homozygous for mutations in the LDLR or APOB genes. We performed function analyses of p.(Leu15Pro) and p.(Gly20Arg) sequence variations.
Citace poskytuje Crossref.org
LDLR gene rearrangements in Czech FH patients likely arise from one mutational event